Daiwa Securities Group Inc. Has $150,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Daiwa Securities Group Inc. boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,028 shares of the financial services provider’s stock after purchasing an additional 110 shares during the period. Daiwa Securities Group Inc.’s holdings in iShares Biotechnology ETF were worth $150,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in IBB. Blue Fin Capital Inc. increased its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after purchasing an additional 74 shares in the last quarter. Security National Bank of SO Dak grew its stake in iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after buying an additional 75 shares during the last quarter. SPC Financial Inc. grew its stake in iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its holdings in shares of iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares in the last quarter. Finally, Main Street Financial Solutions LLC raised its stake in shares of iShares Biotechnology ETF by 1.0% in the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after acquiring an additional 82 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $141.55 on Monday. The business has a fifty day moving average of $142.71 and a 200-day moving average of $142.06. iShares Biotechnology ETF has a twelve month low of $119.95 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.